How do β-blockers improve ventricular function in patients with congestive heart failure?

Circulation

Volumn 107, Issue 19, 2003, Pages 2395-2397

  Barry, William H ^a   Gilbert, E Michael ^b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

Editorials; Heart failure; Receptors, adrenergic, beta; Ventricles

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; ISOPRENALINE; NORADRENALIN; RYANODINE RECEPTOR; RYANODINE RECEPTOR 2; TACROLIMUS; UNCLASSIFIED DRUG;

BETA ADRENERGIC RECEPTOR BLOCKING; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISSOCIATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EDITORIAL; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE FUNCTION; HUMAN; INOTROPISM; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SARCOPLASMIC RETICULUM; SODIUM CALCIUM EXCHANGE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; CALCIUM; CYCLIC AMP; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; RECEPTORS, ADRENERGIC, BETA; SARCOPLASMIC RETICULUM; TACROLIMUS BINDING PROTEINS; VENTRICULAR FUNCTION;

EID: 0038179669     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000070984.65122.9C     Document Type: Editorial

References (22)

1. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
2. Foody JM, Farrell MH, Krumholz HM. β-blocker therapy in heart failure. JAMA. 2002;287:883-889.
3. Olsen SL, Gilbert EM, Renlund DG, et al. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol. 1995;25:1225-1231.
4. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
5. Gilbert EM, Abraham WT, Olsen S, et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 1996; 94:2817-2825.
6. Mann DL, Kent RL, Parsons B, et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992;85:790-804.
7. Alpert NR, Leavitt BJ, Ittleman FP, et al. A mechanistic analysis of the force-frequency relation in non-failing and progressively failing human myocardium. Basic Res Cardiol. 1998;93(suppl 1):23-32.
8. 2+ exchange in failing myocardium. Circ Res. 2000; 87:529-531.
9. Miyata S, Minobe W, Bristow MR, et al. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res. 2000;86: 386-390.
10. Lowes BD, Gilbert EM, Abraham WT, et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med. 2002;346:1357-1365.
11. Reiken S, Wehrens XHT, Vest JA, et al. β-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation. 2003;107:2459-2466.
12. Frank KF, Bolck B, Brixius K, et al. Modulation of SERCA: implications for the failing human heart. Basic Res Cardiol. 2002;97(suppl 1):172-178.
13. Zaccolo M, Pozzan T. Discrete microdomains with high concentration of camp in stimulated rat neonatal cardiac myocytes. Science. 2002;95: 1711-1715.
14. Yano M, Ono K, Ohkusa T, et al. Altered stoichiometry of FKP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure. Circulation. 2000;102:2131-2136.
15. i differ in mouse and rabbit ventricular myocytes. J Pharmacol Exp Ther. 2003;304:334-341.
16. 2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res. 2002;91:1015-1022.
17. Terentyev D, Viatchenko-Karpinski S, Smirnov A, et al. Activation of SR Ca release by protein phosphatases in myocytes from normal and failing rat hearts. Biophys J. 2003;89:200A. Abstract.
18. 2+ transients in rat cardiac myocytes. Circ Res. 1996;79:1110-1121.
19. Marks AR. Cellular functions of immunophilins. Physiol Rev. 1996;76: 631-649.
20. Atkison P, Joubert G, Barron A, et al. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet. 1995; 345:894-896.
21. Meyer M, Trost SU, Bluhm WF, et al. Impaired sarcoplasmic reticulum function leads to contractile dysfunction and cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2001;280:H2046-H2052.
22. Lokuta AJ, Meyers MB, Sander PR, et al. Modulation of cardiac ryanodine receptors by sorcin. J Biol Chem. 1997;272:25333-25338.